Japanese company profile · 368A
Kitazato Corporation
English company name recorded in Japan's EDINET filer data.
Original Japanese company name: 株式会社北里
Name follows the English name recorded in EDINET filer data. English company name source
FY2025 · fiscal year ended March 2026Latest filing date: 2026-06-24What does this company do?
What does this company do?
In its FY2025 public filing, Kitazato Corporation reports Medical Devices Business. The page shows business-level revenue and profit where the source disclosures support comparison.
Kitazato Corporation's largest reported business by revenue in FY2025 was Medical Devices Business.
The business with the highest reported segment profit in FY2025 was Medical Devices Business.
FY2025 · fiscal year ended March 2026 · View original filing ↗ The source document may be in Japanese.
Reported company-wide figures
- Company revenue
- ¥10.95B ↗ FY2025 · fiscal year ended March 2026
- Operating profit
- ¥5.86B ↗ FY2025 · fiscal year ended March 2026
- Comparable margin
- 53.5% ↗ FY2025 · fiscal year ended March 2026
JGAAP · Consolidated company-wide
Company profile
Identity
- Securities code
- 368A
- EDINET code
- E40668
- Corporate number
- 9010001108188
- Listing status
- Listed
- Industry (EDINET filer classification)
- Precision instruments
Location and fiscal year
- Headquarters
- 静岡県富士市 · As filed in Japanese
- Fiscal year end
- 3month
- Latest fiscal year
- FY2025
- Accounting standard
- JGAAP
- P16 data snapshot
- 2026-11-07
Company size
- Employees (consolidated)
- 83 people (FY2025)
- Employees (non-consolidated)
- 75 people (FY2025)
- Capital stock
- JPY 10.0 million (FY2025)
Official information
- Latest annual securities report
- Latest annual securities report Opens in a new tab
Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab
Business structure
How does it make money?
Revenue leader and profit leader
Medical Devices Business
| Business | Sales | Share of company sales | Operating profit | Margin |
|---|---|---|---|---|
| Medical Devices Business | ¥10.95B ↗ | — | ¥5.86B ↗ | 53.5% |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.
Company revenue
Company-wide trend
Company revenue
JGAAP · Consolidated- FY2024
94.1 ¥10.3B - FY2025
100.0 ¥10.95B
Company operating profit
JGAAP · Consolidated- FY2024
98.7 ¥5.78B - FY2025
100.0 ¥5.86B
Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Medical Devices Business | ¥10.3B | ¥10.95B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
No comparable reported revenue growth is available.
What has changed?
What has changed?
A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.
Source
Company profile
These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.
- GrowthPeer-position scoreFY2025
54 - ProfitabilityPeer-position scoreFY2025
100 - Business concentration—No comparable data
- Business change—No comparable data
- Cash generationPeer-position scoreFY2025
100 - Growth persistence—No comparable data
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YIB6
View original filing ↗